Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Spallarossa

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
European Journal of Medicinal Chemistry|August 13, 2011
Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptorElena Cichero, Alessia Ligresti, Marco Allarà, et al.
International Journal of Molecular Sciences|June 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma CellsErika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actionsAngelo Ranise, Andrea Spallarossa, Olga Bruno, et al.
Journal of Medicinal Chemistry|December 13, 2018
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7Vittoria Zoppi, Scott J Hughes, Chiara Maniaci, et al.
European Journal of Medicinal Chemistry|December 9, 2008
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agentsAndrea Spallarossa, Chiara Caneva, Matteo Caviglia, et al.
Journal of Medicinal Chemistry|May 27, 2005
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivativesAngelo Ranise, Andrea Spallarossa, Sara Cesarini, et al.
Journal of Medicinal Chemistry|October 13, 2007
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in miceFabrizio Manetti, Annalisa Santucci, Giada A Locatelli, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
European Journal of Medicinal Chemistry|August 13, 2011
Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptorElena Cichero, Alessia Ligresti, Marco Allarà, et al.
International Journal of Molecular Sciences|June 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma CellsErika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actionsAngelo Ranise, Andrea Spallarossa, Olga Bruno, et al.
Journal of Medicinal Chemistry|December 13, 2018
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7Vittoria Zoppi, Scott J Hughes, Chiara Maniaci, et al.
European Journal of Medicinal Chemistry|December 9, 2008
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agentsAndrea Spallarossa, Chiara Caneva, Matteo Caviglia, et al.
Journal of Medicinal Chemistry|May 27, 2005
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivativesAngelo Ranise, Andrea Spallarossa, Sara Cesarini, et al.
Journal of Medicinal Chemistry|October 13, 2007
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in miceFabrizio Manetti, Annalisa Santucci, Giada A Locatelli, et al.
Pageof 7